StockData
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

LEMAITRE VASCULAR INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)

Close on Oct 19, 2026

Market cap
$2.02B
P/E (TTM)
28.9
Dividend yield
0.97%

LEMAITRE VASCULAR INC balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
72.9%
Operating margin
29.5%
Net margin
25.0%
Return on equity, FY2025
15.8%

Financial strength

Current ratio
16.31
Debt to equity
–
Debt to assets
–
Cash to current liabilities
88.9%

Valuation

P/E ratio
28.9
Price to sales
7.69
Price to book
4.80
Dividend yield
0.97%